BioWin

What BioWin does

BioWin is a non-profit health innovation cluster organization (asbl) founded in 2006 under the leadership of the Walloon Government to drive economic impact through collaborative innovation in the life sciences sector. Headquartered in Namur, Belgium, it operates as the designated competitiveness cluster for the Walloon Region's health-tech and biopharma ecosystem, connecting 260+ member organizations — including 158 industrial companies, 81 service partners, 10 research centres, and 5 universities — alongside hospitals and academic institutions. Its core product is the BioWin Health Innovation Network, around which it bundles a suite of services: innovation stewardship (project shaping, partner matchmaking, 85% funding-application success rate), three annual funding calls (project budgets €1M–€4M with 40–80% grant coverage), international development via its AWEX partnership, talent programs tied to the regional university system, and event platforms (BioWin Days, Morning Clubs, Science for Health, international trade-fair missions). BioWin does not develop proprietary technology; its platform is relational and organizational rather than software-based.

Commercially, BioWin runs on a subscription revenue model comprising annual membership fees from industrial companies with R&D or production activities in Wallonia, and partner fees from service providers without R&D/production activities. Specific fee tiers are not publicly disclosed. The organization is governance-led, with a CEO (Sylvie Ponchaut), COO (David Honba), and a small core team of approximately 10–15 staff organized across business development, innovation and scientific excellence, network and event management, operations, marketing, and legal. BioWin does not have a parent company or external investors and is supported by public co-financing from the Walloon Government alongside its subscription income. Since inception, it has supported 93 R&D projects and members have collectively raised €318.25M in public-private funding, demonstrating BioWin's primary role as a regional innovation intermediary rather than a venture or product company.

Name

BioWin

Legal name

BioWin asbl

Website

https://biowin.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Short description

BioWin is a Wallonia-based non-profit health innovation cluster connecting 260+ life sciences companies, research centres, universities, and hospitals, providing funding access, R&D project stewardship, and international development through annual memberships and public co-financing.

Ownership category

akta.pro rank

Headquarters

HQ city

Gosselies

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership fees: BioWin generates revenue through annual membership fees from organizations in the health-tech and biopharma sectors. Membership provides access to networking, funding support, events, and collaborative innovation opportunities.
2. Partner fees: Supporting organizations without R&D and/or production activities can become partners for annual fees, receiving community connection, visibility boost, and ecosystem engagement benefits.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels10 records

Core offering

BioWin is the health-tech and biopharma innovation cluster of Wallonia, Belgium, operating as a member-driven network that connects 260+ life sciences organizations including industrial companies, research centers, hospitals, and academic institutions. It provides innovation support services such as R&D project stewardship, regional and European funding application assistance, international development via AWEX partnership, talent development programs, visibility and communication services, and networking events including the annual BioWin Days conference.

Product overview

BioWin is a member-driven health-tech and biopharma innovation cluster organization based in Wallonia, Belgium, not a software product company. It operates as a network of 260+ organizations offering collaborative innovation support rather than a unified software platform. The core offering is the BioWin Health Innovation Network, which connects life sciences companies, research centers, hospitals, and universities through a suite of services including innovation support, R&D project facilitation, funding access, international development, talent solutions, communication services, event organization, and a member directory. These services work together to accelerate Belgian health-tech and biopharma innovation, with over €318.25M raised by members through public-private funding and 93 supported R&D projects since 2006.

Differentiator

Problem solved

Functional benefit

Products and services

• BioWin Health Innovation Network Membership Annual membership for organizations engaged in R&D and/or production activities in health-tech and biopharma across Wallonia. Members gain access to network events, funding support, partnership opportunities, international development, and eligibility for board positions.
• Innovation Support Services Project stewardship services including strategic assistance for product portfolio construction, partner connections for collaborative projects, and funding application support including Walloon Regional Government funding applications.
• Funding Opportunities Platform Coordinates three project calls per year offering grants covering 40-80% of project budgets (ranging from €1M to €4M). Includes support for regional, national (Win4Company, BELCOO), and European funding mechanisms including INTERREG and joint funding with MEDVIA.
• International Development Services Support for global expansion of members including connections to partners, market opportunities, and international collaboration facilitation. Includes promotion of Walloon life sciences globally in collaboration with AWEX and joint missions to international trade fairs such as BIO-Europe.
• Talent Development Services Programs addressing talent gaps through collaborative workshops with industry, training centers, and academia. Includes job board access for posting vacancies and connecting with talent in Wallonia's biopharma and health-tech sectors.
• Communication and Visibility Services Targeted communication strategies including member directory listings, event participation, email and social media promotion, blog features, and thematic flyers to strengthen Wallonia's profile and maximize member visibility.
• Events Platform Regular events including BioWin Days (annual conference gathering ~400 regional and global life sciences professionals), Morning Clubs, Nuclear Medicine in Belgium conferences, Healthtech Investor Summit, and international trade fair participation to foster collaboration and innovation exchange.
• Member Directory and Marketplace

Quantifiable outcome

• 85% of projects submitted for regional funding are accepted
• +2 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eleven partnerships are on record, tiered core partnership, strategic partner and minor.

• Oncidium Foundationcore partnershipStrategic or Co-development Partner · 17 October 2025MoU signed to strengthen the nuclear medicine and radiopharmaceutical ecosystem in Belgium and beyond. Joint steering committee led by David Honba (BioWin) and Efrain Perini (Oncidium) to align strategic priorities, co-organize advocacy initiatives, and engage with public authorities, hospitals, and research institutions.
• Deloittestrategic partnerImplementation/ SI/ Consulting PartnerDeloitte serves as a strategic partner providing finance & insurance, innovation & strategic development consulting, market access, and regulatory affairs expertise to BioWin members.
• PwCstrategic partnerImplementation/ SI/ Consulting PartnerPwC is a strategic partner offering professional services including audit, consulting, tax, and advisory services to the BioWin ecosystem.
• Akkodisstrategic partnerImplementation/ SI/ Consulting PartnerAkkodis provides innovative consultancy services and solutions in smart industry, supporting BioWin members with technical expertise.
• MEDVIAcore partnershipStrategic or Co-development PartnerBioWin collaborates with MEDVIA (Flanders health-tech cluster) to support open innovation between Wallonia and Flanders through joint funding calls and collaborative projects.
• Bioviacore partnershipStrategic or Co-development PartnerIndustry-driven membership organization fostering health innovation in Flanders. Biovia partnered with BioWin on the REVIVE project for advanced therapies in burn treatment.
• Wallonia Export & Investment Agency (AWEX)core partnershipGTM or Marketing PartnerAWEX collaborates closely with BioWin to promote Walloon life sciences globally, support members in international growth, attract foreign investment, and facilitate international missions.
• Service Public de Wallonie (SPW)core partnershipOthersPublic authority providing support and funding instruments for Walloon innovation ecosystem. BioWin facilitates project funding applications through SPW.
• VLAIOminorOthersFlemish Innovation & Entrepreneurship agency. Involved in interregional projects like REVIVE with combined SPW/VLAIO funding.
• NEXUS Consortium (IBA, Elysia, ULB, VUB)core partnershipStrategic or Co-development PartnerInterregional consortium developing targeted radiopharmaceutical therapies using astatine-211 for aggressive cancers like glioblastoma. Budget approximately €6.6M combining public and private funding.
• REVIVE Consortium (BioWin, Biovia)core partnershipStrategic or Co-development PartnerInterregional project on advanced therapies for burn treatment. Total budget €5.56M combining SPW and VLAIO public funding with private investments. Developing three complementary therapeutic solutions using stem cell-derived active pharmaceutical ingredients in hydrogel biomaterials.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Sciensano: Belgian federal public health research institute. While not a cluster, Sciensano is a complementary health-research actor in Belgium that overlaps with BioWin's stakeholder network and its mission of accelerating health innovation.

Regional players

• Life Sciences Hub Wales: Welsh Government-backed organization driving health and life sciences innovation. Similar public-sector-backed, cluster-coordination model to BioWin, though focused on adoption and industry engagement rather than R&D funding.
• Lyonbiopôle: French health cluster serving the Auvergne-Rhône-Alpes region with a similar focus on biopharma, diagnostics, and medtech. Operates under the same 'pôle de compétitivité' model as BioWin, making it a strong structural peer.
• One Nucleus: UK-based membership organization for life sciences and genomics companies in the Cambridge-London corridor. Comparable in its member-driven, networking-and-events-led model, though with a national rather than regional remit.
• Biocat: Catalonia's bioregion umbrella organization coordinating biotech, medtech, and digital health stakeholders. Structurally analogous to BioWin in its cluster-coordination role within a defined Spanish region.

Broad incumbents

• Medicen Paris Region: Paris-region health cluster supporting biopharma, medtech, and digital health innovation. Comparable in scope and ambition to BioWin, though operating in a much larger geographic and economic footprint.
• Massachusetts Biotechnology Council (MassBio): Large US life sciences trade association with 1,600+ members, providing networking, policy advocacy, and industry intelligence. A scaled-up analogue of BioWin's networking and advocacy functions in a more mature biotech market.
• BioM (Bavaria): Munich-based biotech cluster organization with a network of 350+ member companies, broadly comparable in member scale and biotech focus. Operates in a more established biotech region than Wallonia.

Direct peers

• Biovia (Flanders): Flemish health innovation cluster focused on biopharma and health-tech. BioWin co-led the REVIVE interregional advanced therapies project with Biovia, evidencing a closely aligned mission and member profile.
• MEDVIA: Flanders-based health-tech innovation cluster with a similar mandate of connecting industry, academia, and clinical partners. BioWin and MEDVIA already run joint funding calls, making them the most direct comparable in Belgium.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Biowin_asbl
• YouTubeyoutube.com/channel/UCmAnd-Jz6p0fkaWFB7jePUQ
• LinkedInlinkedin.com/company/biowin

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioWin